These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9814657)

  • 1. Stem cell transplantation and intensified cytotoxic treatment for myelodysplasia.
    Boogaerts MA
    Curr Opin Hematol; 1998 Nov; 5(6):465-71. PubMed ID: 9814657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
    Beran M
    Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation in myelodysplastic syndromes.
    de Witte T; Suciu S; Brand R; Muus P; Kröger N
    Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemopoietic stem cell transplantation for myelodysplastic syndrome.
    Deeg HJ; Appelbaum FR
    Curr Opin Oncol; 2000 Mar; 12(2):116-20. PubMed ID: 10750721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation strategies for the management of patients with myelodysplastic syndromes.
    Meletis J; Terpos E
    J BUON; 2009; 14(4):551-64. PubMed ID: 20148443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and prognostic factors in myelodysplastic syndromes.
    Boogaerts MA; Verhoef GE; Demuynck H
    Baillieres Clin Haematol; 1996 Mar; 9(1):161-83. PubMed ID: 8730556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
    Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.
    Mishra A; Anasetti C
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S49-52. PubMed ID: 27521324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in intensive chemotherapy for high-risk myelodysplastic syndromes.
    Sanz GF; Sanz MA
    Forum (Genova); 1999; 9(1):63-71. PubMed ID: 10101211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell transplantation for patients with myelodysplastic syndrome and secondary leukemias.
    De Witte T
    Int J Hematol; 2000 Aug; 72(2):151-6. PubMed ID: 11039662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of high-risk myelodysplastic syndromes.
    Pisani FD; Rainaldi A
    Crit Rev Oncol Hematol; 2001 Dec; 40(3):215-28. PubMed ID: 11738945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
    Deeg HJ; Appelbaum FR
    Leuk Res; 2000 Aug; 24(8):653-63. PubMed ID: 10936419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
    Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia.
    Oosterveld M; de Witte T
    Blood Rev; 2000 Dec; 14(4):182-9. PubMed ID: 11124106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
    Spitzer B; Jakubowski AA; Papadopoulos EB; Fuller K; Hilden PD; Young JW; Barker JN; Koehne G; Perales MA; Hsu KC; van den Brink MR; Kernan NA; Prockop SE; Scaradavou A; Castro-Malaspina H; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2088-2095. PubMed ID: 28711727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
    Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
    Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome.
    de Witte T; Oosterveld M; Muus P
    Blood Rev; 2007 Jan; 21(1):49-59. PubMed ID: 16822600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life after hypomethylating agents in myelodysplastic syndrome: new strategies.
    Santini V
    Curr Opin Hematol; 2015 Mar; 22(2):155-62. PubMed ID: 25603477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.